Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.

Assassi S, Wang X, Chen G, Goldmuntz E, Keyes-Elstein L, Ying J, Wallace PK, Turner J, Zheng WJ, Pascual V, Varga J, Hinchcliff ME, Bellocchi C, McSweeney P, Furst DE, Nash RA, Crofford LJ, Welch B, Pinckney A, Mayes MD, Sullivan KM
Ann Rheum Dis. 2019 78 (10): 1371-1378

PMID: 31391177 · PMCID: PMC7167108 · DOI:10.1136/annrheumdis-2019-215770

MeSH Terms (19)

Adult Cyclophosphamide Down-Regulation Female Hematopoietic Stem Cell Transplantation Humans Interferons Male Middle Aged Multilevel Analysis Myeloablative Agonists Neutrophils Randomized Controlled Trials as Topic Scleroderma, Systemic Transcriptome Transplantation, Autologous Transplantation Conditioning Treatment Outcome Up-Regulation

Connections (1)

This publication is referenced by other Labnodes entities:

Links